ES557072A0 - Procedimiento para la obtencion de lineas celulares de hibridoma - Google Patents

Procedimiento para la obtencion de lineas celulares de hibridoma

Info

Publication number
ES557072A0
ES557072A0 ES557072A ES557072A ES557072A0 ES 557072 A0 ES557072 A0 ES 557072A0 ES 557072 A ES557072 A ES 557072A ES 557072 A ES557072 A ES 557072A ES 557072 A0 ES557072 A0 ES 557072A0
Authority
ES
Spain
Prior art keywords
human mif
cell lines
monoclonal antibodies
derivatives
hybridoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES557072A
Other languages
English (en)
Other versions
ES8801850A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES557072A0 publication Critical patent/ES557072A0/es
Publication of ES8801850A1 publication Critical patent/ES8801850A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
ES557072A 1984-05-24 1986-09-16 Procedimiento para la obtencion de lineas celulares de hibridoma Expired ES8801850A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH255784 1984-05-24
CH378684 1984-08-07
CH544684 1984-11-14
CH51285 1985-02-05

Publications (2)

Publication Number Publication Date
ES557072A0 true ES557072A0 (es) 1987-08-01
ES8801850A1 ES8801850A1 (es) 1987-08-01

Family

ID=27427909

Family Applications (3)

Application Number Title Priority Date Filing Date
ES543391A Expired ES8702950A1 (es) 1984-05-24 1985-05-22 Procedimiento para la obtencion purificada de un factor de inhibicion de la emigracion de macrofagos humanos
ES557071A Expired ES8801852A1 (es) 1984-05-24 1986-09-16 Procedimiento para la obtencion de anticuerpos monoclonales contra el factor de inhibicion de emigracion de macrofagos humanos.
ES557072A Expired ES8801850A1 (es) 1984-05-24 1986-09-16 Procedimiento para la obtencion de lineas celulares de hibridoma

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES543391A Expired ES8702950A1 (es) 1984-05-24 1985-05-22 Procedimiento para la obtencion purificada de un factor de inhibicion de la emigracion de macrofagos humanos
ES557071A Expired ES8801852A1 (es) 1984-05-24 1986-09-16 Procedimiento para la obtencion de anticuerpos monoclonales contra el factor de inhibicion de emigracion de macrofagos humanos.

Country Status (8)

Country Link
EP (1) EP0162812B1 (es)
JP (3) JPH0672158B2 (es)
AT (1) ATE93869T1 (es)
DE (1) DE3587553D1 (es)
DK (1) DK171646B1 (es)
ES (3) ES8702950A1 (es)
IE (1) IE60450B1 (es)
IL (1) IL75280A0 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8623850D0 (en) * 1986-10-03 1986-11-05 Ciba Geigy Ag Lymphokine related peptide
EP0263072B1 (en) * 1986-10-03 1994-03-23 Ciba-Geigy Ag Novel lymphokine related peptides
WO1990011301A1 (en) * 1989-03-17 1990-10-04 Genetics Institute, Inc. Human macrophage migration inhibitory factor
GB8915414D0 (en) * 1989-07-05 1989-08-23 Ciba Geigy Novel cytokines
US5107906A (en) * 1989-10-02 1992-04-28 Swenson Paul F System for fast-filling compressed natural gas powered vehicles
US5149544A (en) * 1989-11-13 1992-09-22 Research Corporation Technologies, Inc. Method of inhibiting progenitor cell proliferation
DE69435303D1 (de) * 1993-05-17 2010-09-02 Cytokine Pharmasciences Inc Er behandlung von krankheiten bei denen eine cytok
US6645493B1 (en) * 1993-05-17 2003-11-11 The Picower Institute For Medical Research Composition containing anti-MIF antibody
AU2001238677A1 (en) * 2000-02-28 2001-09-12 Idec Pharmaceuticals Corporation Method for preparing anti-mif antibodies
DE10121255A1 (de) 2001-04-30 2002-11-07 Switch Biotech Ag Verwendung von alpha 1-Antichymotrypsin Polypeptiden oder diese kodierende Nukleinsäuren, oder einer ein ACT Polypeptid oder diese kodierende Nukleinsäure exprimierende Zelle, zur Behandlung und/oder Prävention von diabetes-assoziierten und/oder arteriellen schlecht heilenden Wunden und zur Identifizierung von pharmakologisch aktiven Substanzen
UY27304A1 (es) 2001-05-24 2002-12-31 Avanir Pharmaceuticals Inhibidores del factor inhibidor de la migración de los macrófagos y métodos para su identificación
TW200418829A (en) 2003-02-14 2004-10-01 Avanir Pharmaceutics Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
BRPI0609382A2 (pt) 2005-03-24 2010-03-30 Avanir Pharmaceuticals derivados da tienopiridinona como inibidores do fator inibitório de migração de macrófagos
CN100457895C (zh) * 2006-05-24 2009-02-04 中国科学院生物物理研究所 鼠抗人巨噬细胞迁移抑制因子单克隆抗体及其应用
WO2013050453A1 (en) * 2011-10-07 2013-04-11 Baxter Healthcare S.A. Oxmif as a diagnostic marker

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2755363C3 (de) * 1977-12-12 1983-12-01 R & Z Biologicals Beteiligungsgesellschaft mbH, 4050 Mönchengladbach Testverfahren zur Diagnose von Malignomen
US4299814A (en) * 1979-05-25 1981-11-10 Monsanto Company Radioimmunoassay of MIF
JPS5939832A (ja) * 1982-08-28 1984-03-05 Ajinomoto Co Inc モノクロ−ナル抗体ならびにその製法、使用法
DD230876A1 (de) * 1983-05-09 1985-12-11 Akad Wissenschaften Ddr Verfahren zur gewinnung monoklonaler antikoerper gegen human-mif

Also Published As

Publication number Publication date
IE60450B1 (en) 1994-07-13
DK171646B1 (da) 1997-03-03
ES557071A0 (es) 1988-02-16
JPH06217789A (ja) 1994-08-09
JPS60248617A (ja) 1985-12-09
IL75280A0 (en) 1985-09-29
EP0162812A3 (en) 1988-04-20
DK229985A (da) 1985-11-25
DE3587553D1 (de) 1993-10-07
IE851295L (en) 1985-11-24
ATE93869T1 (de) 1993-09-15
JPH0672158B2 (ja) 1994-09-14
DK229985D0 (da) 1985-05-23
ES8801852A1 (es) 1988-02-16
JPH0770192A (ja) 1995-03-14
JPH0780915B2 (ja) 1995-08-30
ES8801850A1 (es) 1987-08-01
EP0162812A2 (de) 1985-11-27
ES8702950A1 (es) 1987-01-16
EP0162812B1 (de) 1993-09-01
ES543391A0 (es) 1987-01-16
JPH07108915B2 (ja) 1995-11-22

Similar Documents

Publication Publication Date Title
ES557072A0 (es) Procedimiento para la obtencion de lineas celulares de hibridoma
FI851334L (fi) Nya monoklonala antikroppar och hybridomaceller, foerfarande foer framstaellning av desamma samt deras anvaendning.
Yoshizaki et al. Induction of proliferation and Ig production in human B leukemic cells by anti-immunoglobulins and T cell factors.
DE3586536T2 (de) Monoklonaler antikoerper gegen ein cytotoxin, denselben erzeugendes hybridoma und verfahren fuer die herstellung des gereinigten cytotoxin.
DK101890A (da) Monoklonale antistoffer mod human interleukin-4 og hybridomaer, der producerer saadanne
ATE245699T1 (de) Rekombinant pgp3, verfahren zu dessen herstellung,und dessen verwendung in der diagnose und therapie
NO150015C (no) Fremgangsmaate ved blodstroemhastighetsmaaling med ultralyd, kombinert med ekko-amplitudeavbildning, for undersoekelse av levende biologiske strukturer
DK113389A (da) Monoklonale antistoffer
IT1150682B (it) Procedimento per la produzione di sostanze prodotte da cellule,particolarmente di anticorpi e simili
NO174110C (no) Monoklonalt antistoff til anvendelse in vitro for diagnose av maligne tumor- eller akutte inflammasjonssykdommer, og som er spesifikt for N-acetyl-neuraminsyre i hybridom som produserer antistoffet
ES514387A0 (es) "metodo para la determinacion de las proteinas glicosiladas presentes en fluidos biologicos".
ATE73463T1 (de) Monoklonale antikoerper.
Kishimoto et al. Polymorphism of submandibular-sublingual salivary proteins which promote adhesion of Streptococcus mutans serotype-c strains to hydroxyapatite
IT1213222B (it) Metodo per la determinazione quantitativa di componenti fisiologici in fluidi biologici.
DK270386A (da) Monoklonalt antistof til humant protein c, dets fremstilling og anvendelse
IT8485664A0 (it) Procedimento per il trattamento di liquami di conceria con ricupero di torbide proteiche utilizzabili in zootecnia.
ES267569Y (es) "conjunto para la practica de analisis clinicos".
ES502825A0 (es) Procedimiento para la fabricacion de vino de platano

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20000201